Lv610
2470 积分 2022-11-27 加入
How I treat HLH-like toxicities after immune effector cell therapy
26天前
已关闭
Hemophagocytic lymphohistiocytosis in adults
26天前
已完结
Neoantigen-based TCR-T therapy in solid tumors
26天前
已完结
T-Cell Receptor Engineered T-Cell Therapy
26天前
已关闭
Safety and efficacy of the eCLIPs bifurcation remodelling system for the treatment of wide necked bifurcation aneurysms: 1 year results from the European eCLIPs Safety, Feasibility, and Efficacy Study (EESIS)
29天前
已完结
Preserving and Promoting Clinical Trial Representativeness
29天前
已完结
MASLD, MASH, and the CKM Spectrum
29天前
已完结
Evidentiary Landscape of Heart Failure Therapies, Regulatory Decisions, and Translation Into Guidelines
1个月前
已完结
Emerging Role of Novel Therapeutics
1个月前
已完结
Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio
1个月前
已完结
皖公网安备34019202002308
